PTAB: Unidirectional Language of AIA Estoppel Dooms Common-Law Claim Preclusion Argument Based on District Court’s Final Judgment of No Invalidity

July 24, 2023

Reading Time : 2 min

By: Caitlin E. Olwell, Rubén H. Muñoz, Ange Christiani (Law Clerk)

The Patent Trial and Appeal Board has denied a patent owner’s motion to terminate an inter partes review proceeding finding that the unidirectional nature of estoppel under 35 U.S.C. § 315(e) renders common-law claim preclusion inapplicable as a basis for termination.

Patent Owner moved to terminate an IPR after Petitioner successfully joined the proceeding, which was originally filed by another party. Because Petitioner had unsuccessfully litigated invalidity of the patent in district court, Patent Owner argued that termination was proper on a theory of claim preclusion. The district court had issued a final judgment of no invalidity after Patent Owner and Petitioner had fully and fairly argued their cases. Petitioner’s joinder in the IPR, Patent Owner alleged, was nothing more than a collateral attack on the final judgment. Petitioner responded that common-law claim preclusion does not apply to IPRs due to differing burdens of proof between district court actions and IPRs, and the proceedings lacking the same nucleus of operative facts. 

While the Board ultimately decided in favor of Petitioner, it shored up its analysis on three prongs of support: (1) the opinion of the Court in Astoria Fed. Sav. & Loan Ass’n v. Solimino, 501 U.S. 104 (1991), (2) the explicit language in the AIA, 35 U.S.C. § 315(e) and (3) the Congressional intent in passing 35 U.S.C. § 315(e). 

First, the Board found that contrary to Patent Owner’s interpretation, Astoria stood for the premise that the presumption of common-law preclusion exists only as far as “Congress has failed to expressly or impliedly evince any intention on the issue.”

Second, the Board dissected the language of 35 U.S.C. § 315(e) and found that it exhibits a one-way avenue. According to the Board, Section 315(e) states that following a final written decision, the petitioner in an IPR “may not request or maintain a proceeding before the Office,” nor “assert either in a civil action…or in a proceeding before the ITC” a challenge to a claim on a ground petitioner “raised or reasonably could have raised during the inter partes review.” The Board further noted that the statute is silent on the reverse scenario: a party in a fully-litigated district court action later challenging the same claim on the same grounds in an IPR.

Third, the Board concluded that Congress’ act of passing the AIA, which contained its own specific estoppel provisions, “evinced” the intention that common-law claim preclusion was superseded. The Board determined that existence of different burdens of proof between IPRs and district court actions, the removal of the dual-directional language from the predecessor statute to IPR (inter partes reexamination (35 U.S.C. § 317)) and the need to give effect to § 315—which would become redundant if interpreted to be multi-directional—all evidenced Congress’ intent for IPR estoppel as a unidirectional barricade.

Practice Tip: With its one-way estoppel provision confirmed by at least one PTAB panel, the AIA appears to provide patent challengers a second bite at the apple in an IPR proceeding. After receiving a final judgment in district court, patent challengers who fail to prove invalidity by clear-and-convincing evidence may not be precluded from bringing the same claims and evidence against a patentee under a lower burden of proof, and should consider this avenue as a viable option in their overall litigation strategy.

OpenSky Indus. v. VLSI Tech. LLC, IPR2021-01064, Paper 132 (P.T.A.B. Apr. 4, 2023)

Share This Insight

Previous Entries

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of
products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.
...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal
of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims
were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an
attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.
...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of
the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug
product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and
the related statutory context.
...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition
challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged
claim construction issues or the number, length or scope differences of the challenged claims.
...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the
Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel
litigation. Weighing the factors as a whole, the Director determined that institution should be denied.
...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a
parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB
would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in
view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.
...

Read More

IP Newsflash

April 23, 2025

The Federal Circuit recently refused to apply collateral estoppel to claims of a patent asserted in district court litigation based on a Patent Trial and Appeal
Board (PTAB) decision finding similar claims from the same patent unpatentable because the PTAB applied a lower burden of proof than what is required to
invalidate claims in district court.
...

Read More

IP Newsflash

April 7, 2025

The Central District of California denied a defendant’s motion to dismiss or transfer plaintiff’s first-filed declaratory judgment action based on defendant’s
later-filed patent infringement suit in Wisconsin.  Though suit was seemingly imminent when defendant advised plaintiff it might be infringing defendant’s
patents, plaintiff responded by requesting a licensing agreement in lieu of litigation. The court found that plaintiff’s action was not anticipatory
forum-shopping litigation because plaintiff only filed suit after defendant neglected to respond to its licensing offer.
...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.